These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 19783238)

  • 21. Advances in bronchopulmonary dysplasia.
    Strueby L; Thébaud B
    Expert Rev Respir Med; 2014 Jun; 8(3):327-38. PubMed ID: 24666156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased incidence of bronchopulmonary dysplasia in preterm infants exposed to preeclampsia.
    Ozkan H; Cetinkaya M; Koksal N
    J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2681-5. PubMed ID: 22759075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does the experience with the use of nasal continuous positive airway pressure improve over time in extremely low birth weight infants?
    Aly H; Milner JD; Patel K; El-Mohandes AA
    Pediatrics; 2004 Sep; 114(3):697-702. PubMed ID: 15342841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention and therapy of bronchopulmonary dysplasia - evidence and clinical practice.
    Thomas W; Speer CP
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Jun; 9(3):264-77. PubMed ID: 17582275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of bronchopulmonary dysplasia during an 11-year period in infants weighing less than 1500 g at birth.
    Vanhatalo AM; Ekblad H; Kero P; Erkkola R
    Ann Chir Gynaecol Suppl; 1994; 208():113-6. PubMed ID: 8092762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bronchopulmonary dysplasia and early prophylactic inhaled nitric oxide in preterm infants: current concepts and future research strategies in animal models.
    Rieger-Fackeldey E; Hentschel R
    J Perinat Med; 2008; 36(5):442-7. PubMed ID: 18605970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does bronchopulmonary dysplasia change the postoperative outcome of herniorrhaphy in premature babies?
    Melo-Filho AA; de Fátima Assunção Braga A; Calderoni DR; Volk S; Marba S; Sbragia L
    Paediatr Anaesth; 2007 May; 17(5):431-7. PubMed ID: 17474949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bronchopulmonary dysplasia predicts adverse developmental and clinical outcomes in very-low-birthweight infants.
    Jeng SF; Hsu CH; Tsao PN; Chou HC; Lee WT; Kao HA; Hung HY; Chang JH; Chiu NC; Hsieh WS
    Dev Med Child Neurol; 2008 Jan; 50(1):51-7. PubMed ID: 18173631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevalence and risk factors of bronchopulmonary dysplasia among extremely low birth weight newborns of regional birth cohort of south-east Poland].
    Kwinta P; Grudzień A; Pawlik D; Olechowski W; Lauterbach R; Pietrzyk JJ
    Przegl Lek; 2009; 66(1-2):14-20. PubMed ID: 19485250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [From classic to new bronchopulmonary dysplasia].
    Kramer BW; Lievense S; Been JV; Zimmermann LJ
    Ned Tijdschr Geneeskd; 2010; 154():A1024. PubMed ID: 20456770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of bronchopulmonary dysplasia.
    Jensen EA; Schmidt B
    Birth Defects Res A Clin Mol Teratol; 2014 Mar; 100(3):145-57. PubMed ID: 24639412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug therapies in bronchopulmonary dysplasia: debunking the myths.
    Tin W; Wiswell TE
    Semin Fetal Neonatal Med; 2009 Dec; 14(6):383-90. PubMed ID: 19747890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relation of exhaled nitric oxide levels to development of bronchopulmonary dysplasia.
    May C; Williams O; Milner AD; Peacock J; Rafferty GF; Hannam S; Greenough A
    Arch Dis Child Fetal Neonatal Ed; 2009 May; 94(3):F205-9. PubMed ID: 19383857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study.
    Ballard HO; Anstead MI; Shook LA
    Respir Res; 2007 Jun; 8(1):41. PubMed ID: 17550598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.
    Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood cytokines during the perinatal period in very preterm infants: relationship of inflammatory response and bronchopulmonary dysplasia.
    Paananen R; Husa AK; Vuolteenaho R; Herva R; Kaukola T; Hallman M
    J Pediatr; 2009 Jan; 154(1):39-43.e3. PubMed ID: 18760808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bronchopulmonary dysplasia].
    Clément A
    Rev Mal Respir; 1996 Jul; 13(3):243-9. PubMed ID: 8765916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are preterm infants at high altitude at greater risk for the development of bronchopulmonary dysplasia?
    Alshehri MA
    J Trop Pediatr; 2014 Feb; 60(1):68-73. PubMed ID: 24072557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of a physiologic definition on bronchopulmonary dysplasia rates.
    Walsh MC; Yao Q; Gettner P; Hale E; Collins M; Hensman A; Everette R; Peters N; Miller N; Muran G; Auten K; Newman N; Rowan G; Grisby C; Arnell K; Miller L; Ball B; McDavid G;
    Pediatrics; 2004 Nov; 114(5):1305-11. PubMed ID: 15520112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of nutrition in the prevention and management of bronchopulmonary dysplasia.
    Biniwale MA; Ehrenkranz RA
    Semin Perinatol; 2006 Aug; 30(4):200-8. PubMed ID: 16860160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.